Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Desmopressin for coagulation improvement in combined factor V and VIII deficiency
IRCT2015020120894N1Phase 2Completed
- Sponsor
- Mashhad University of Medical Sciences
- Start
- Nov 2009
- Modality
- Small Molecules, Peptides
- Countries
- 1
01
Overview
Phase 2, single-arm trial of desmopressin in combined coagulation factor V and VIII deficiency (F5F8D), sponsored by Mashhad University of Medical Sciences. Primary endpoint: Improvement in coagulation status. Started Nov 2009; status: completed.
02
Drugs
desmopressin
03
Conditions
combined coagulation factor V and VIII deficiency (F5F8D)
Beyond the preview
Go deeper on IRCT2015020120894N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT2015020120894N1.